-+ 0.00%
-+ 0.00%
-+ 0.00%

Legend Biotech Reports CARVYKTI® Delivers Median PFS of 50.4 Months in Multiple Myeloma Trial

路透·12/08/2025 12:30:47

登錄查看新聞詳情